Express Scripts CEO Welcomes Opportunity to Work With Amazon

Tim Wentworth, CEO of Express Scripts, discusses the company's position amidst the CVS and Aetna merger, emphasizing the value of being a standalone PBM. He addresses potential offers from companies like Cigna or Humana and the strategic decisions involved. The conversation also covers Anthem's challenges in building a PBM, future trends like biosimilars, and Amazon's potential market entry. Wentworth highlights the PBM's role in managing drug costs and critiques pharma pricing strategies.

What challenges does Anthem face in building a PBM?

How does Tim Wentworth view the potential entry of Amazon into the pharmacy business?

What is Tim Wentworth's response to the criticism of PBMs regarding drug pricing?